CTOs on the Move

Access Integrated Healthcare

www.accessih.com

 
Founded by Chief Executive Officer Sam Solakyan, Global Holdings, Inc. has excelled in its journey in becoming leaders in each of the industries it has a presence in. Their main responsibility lies in providing their clients with the most premiere level of service. More than just your typical holdings group, Global is a multifaceted company with financial assets and ownership in the radiology, pharmaceuticals, and medical billing and collections industries. Instead of merely buying and selling companies like other holdings groups, Global searches for the less desirable companies with hidden potential and applies its knowledge and expertise in the management ...
  • Number of Employees: 100-250
  • Annual Revenue: $10-50 Million
  • www.accessih.com
  • 550 N. Brand Blvd. 20th Floor
    Glendale, CA USA 91203
  • Phone: 866.460.7465

Executives

Name Title Contact Details

Similar Companies

Medical Specialists of the Palm Beaches

Medical Specialists of the Palm Beaches is a primary care focused, multi-specialty physician group practice serving Palm Beach and Broward counties in Florida. They offer primary care, cardiology, neurology, hematology/oncology, concierge medicine, and...

Legacy Retirement Residence

Legacy Retirement Residence is a South Jordan, UT-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Nueterra

Nueterra Capital is a private equity investment and advisory firm with an exclusive focus on healthcare. Leveraging a deep understanding of key industry drivers, Nueterra Capital invests in entrepreneurs with innovative minds, while providing professional expertise and back office resources to improve their bottom line performance and drive growth. Nueterra Capital has invested in hundreds of new ventures and continuously delivers the resources and strategic direction that allow our partners to advance and improve every aspect of healthcare.

OncoGenex

OncoGenex is a biopharmaceutical company committed to the development and commercialization of new therapies that address treatment resistance in cancer patients. OncoGenex has a diverse oncology pipeline, with each product candidate having a distinct mechanism of action and representing a unique opportunity for cancer drug development. OncoGenex and Teva Pharmaceutical Industries Ltd. have entered a global collaboration and licensing agreement to develop and commercialize OncoGenex' lead drug candidate, custirsen. Custirsen is currently in Phase 3 clinical development as a treatment in men with metastatic castrate-resistant prostate cancer and in patients with advanced, unresectable non-small cell lung cancer. Apatorsen is in Phase 2 clinical development and OGX-225 is currently in pre-clinical development.

Marshalltown Medical Sergical Center

Marshalltown Medical & Surgical Center (MMSC) is the only full service medical center in the area. The 125-bed, not-for-profit facility serves more than 60,000 residents with a wide variety of healthcare services and around-the-clock emergency care. MMSC includes a state-of-the-art Diagnostic Imaging Department, Cardiac Catheterization Lab and Rehabilitation Center, as well as four primary care clinics. The hospital is accredited by the Center for Medicare and Medicaid Services (CMS).